Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3021% above fair value
$19.80−0.09 (-0.45%)
Close on Nov 16, 2026Market cap $1.00BP/E –Yield –
Cryoport total assets
Total assets on the balance sheet at the end of each period.
Cryoport's total assets was $756.20M at Jun 30, 2026. For fiscal 2025 it was $764.99M, up 8.7% from the year before. Over ten years it grew 84.1% a year on average. The highest annual figure on record is $1.11B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $764.99M | +8.7% |
| FY2024 | Dec 31, 2024 | $703.49M | -26.5% |
| FY2023 | Dec 31, 2023 | $957.74M | -7.8% |
| FY2022 | Dec 31, 2022 | $1.04B | -6.7% |
| FY2021 | Dec 31, 2021 | $1.11B | +101.5% |
| FY2020 | Dec 31, 2020 | $552.41M | +306.6% |
| FY2019 | Dec 31, 2019 | $135.87M | +140.0% |
| FY2018 | Dec 31, 2018 | $56.62M | +872.2% |
| FY2016 | Mar 31, 2016 | $5.82M | +123.4% |
| FY2015 | Mar 31, 2015 | $2.61M | +52.4% |
| FY2014 | Mar 31, 2014 | $1.71M | -2.6% |
| FY2013 | Mar 31, 2013 | $1.76M | -71.7% |
| FY2012 | Mar 31, 2012 | $6.21M | -43.7% |
| FY2011 | Mar 31, 2011 | $11.03M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $756.20M | -2.3% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $763.61M | +9.1% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $764.99M | +8.7% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $774.33M | +10.3% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $773.93M | -9.2% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $699.84M | -25.8% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $703.49M | -26.5% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $701.77M | -29.9% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $852.34M | -17.3% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $942.85M | -10.0% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $957.74M | -7.8% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $1.00B | -3.2% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $1.03B | -1.5% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $1.05B | -3.1% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $1.04B | -6.7% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $1.03B | +25.4% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $1.05B | +26.8% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $1.08B | +31.9% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $1.11B | +101.5% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $824.39M | +226.7% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $825.31M | +226.5% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $819.71M | +485.0% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $552.41M | +306.6% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $252.36M | +86.9% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $252.78M | +89.8% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $140.12M | +134.3% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $135.87M | +140.0% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $135.06M | +322.1% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $133.15M | +380.0% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $59.79M | +138.4% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $56.62M | +872.2% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $32.00M | +329.0% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $27.74M | +211.1% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $25.08M | +524.0% |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $5.82M | +123.4% |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | $7.46M | +299.6% |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | $8.92M | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | $4.02M | – |
| Q4 FY2015CQ1 2015 | Mar 31, 2015 | $2.61M | – |
| Q3 FY2015CQ4 2014 | Dec 31, 2014 | $1.87M | – |
See a number that looks wrong?